Engineered Gut Bacteria Target Pancreatic Cancer in Promising Drug-Like Study
Pancreatic cancer is notoriously resistant to immunotherapy because many tumors develop an immune-suppressive, oxygen-poor “cold” microenvironment that blocks effective T ...
